Rate hikes are back on the table and fuel driven inflation is squeezing both households and corporate budgets, yet some large US dividend stocks still aim to offer a measure of calm when markets feel jumpy. Investors scanning for resilient income now risk missing pockets of quality hiding in plain sight. This piece walks through three defensive large caps exposed to the latest Fed and inflation headlines, and explains why they merit a closer look today.
The stocks covered next are a sample set only. The full screen surfaced 9 more large-cap US defensive dividend companies with equally compelling income stories that are not included below. To identify potential fits for your own watchlist, analyze and compare candidates directly inside the Large-Cap US Defensive Dividend Stocks screener.
Abbott Laboratories (ABT)
Overview: Abbott Laboratories is a global healthcare group that sells diagnostics, medical devices, nutrition and generic medicines across multiple patient needs.
Operations: Abbott Laboratories generates most of its roughly US$46.6b revenue from medical devices, diagnostics and nutrition, with smaller pharmaceuticals and other lines.
Market Cap: US$172.3b
For a defensive dividend screen built around essential spending and steadier demand, Abbott Laboratories offers healthcare exposure with multiple everyday use products that can matter when rate hikes and inflation unsettle more cyclical businesses.
"Broader adoption of continuous glucose monitoring, including expected Centers for Medicare and Medicaid Services coverage for non insulin users that could open access to about 10 million additional Medicare beneficiaries, together with the planned U.S. launch of Libre Duo and further system integrations, can support higher CGM sensor volumes and contribute to top line growth."
What really moves the needle for investors is how one less visible pressure ends up shaping future pricing power and cash generation.
That quiet pressure on pricing power is exactly what the full narrative for Abbott Laboratories unpacks, including where cash generation could accelerate or stall next.
Del Monte (DMC)
Overview: Del Monte Corporation produces and sells branded fresh, fresh-cut and prepared fruits and vegetables to retailers and foodservice customers worldwide.
Operations: Del Monte generates most of its roughly US$2.5b revenue from Fresh and Value-Added Products, with bananas and other services contributing the remainder.
Market Cap: US$1.4b
Del Monte brings classic consumer staples exposure to this defensive dividend screen, with everyday fruit and vegetable products that households tend to keep buying even when rates rise and budgets tighten. This puts extra attention on how it handles cost shocks tied to fuel and crops.
"Severe climate impacts (such as port disruptions in Costa Rica and accelerating tropical crop diseases) are presenting escalating operational and cost risks that threaten supply continuity and earnings stability. Current market value may underestimate the drag on long-term profit growth, especially as the company's geographic diversification efforts will take several years to materially offset these risks."
What really matters for Del Monte now is how one unresolved cost squeeze shapes the balance between its dividend, margins and future growth options.
That trade off sits at the heart of the full narrative for Del Monte, which maps how Del Monte could turn today’s cost squeeze into tomorrow’s quietly compounding cash engine.
Hormel Foods (HRL)
Overview: Hormel Foods produces branded meat, nut and convenient meal products for retail, foodservice and international customers, anchoring the consumer staples income side of this defensive dividend screen.
Operations: Hormel Foods generates most of its revenue from Retail at about US$7.3b, with Foodservice at US$4.1b and International near US$721m.
Market Cap: US$10.6b
Hormel Foods brings everyday pantry and refrigerated staples to a market that currently rewards dependable dividend payers. This is one reason its push into higher value protein is drawing fresh attention from income focused investors.
"Hormel Foods is expanding its value added protein and foodservice reach through the planned Brakebush Brothers acquisition, expected to add about US$1.2b of net sales in calendar 2026 and lift higher margin chicken exposure toward 13% of the protein portfolio."
What happens to those margins if one less visible cost pressure moves differently to what both management and analysts are assuming today?
If that cost curve starts to decouple from expectations, the full narrative for Hormel Foods illustrates how Hormel Foods' cash profile and dividend capacity could improve more rapidly.
Seeking Fresh Alternatives Before Others
Markets move fast and the next breakout stories rarely stay quiet for long. Scan fresh momentum while it matters, before others get caught chasing.
- Track cash rich, overlooked operators using the list of solid balance sheet and fundamentals (25 results) and spot businesses that may handle rate and inflation shocks with more room to maneuver.
- Review the 20 cryptocurrency and blockchain stocks and focus on listed plays tied to blockchain rails and infrastructure.
- Scan the 8 dividend fortresses for high yielders that prioritize resilience and highlight income ideas that aim to keep paying while prices keep swinging.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com